DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
AD1099566
Title:
Human Cell Line Activation Test of the Novel Energetic N,N'- bis(4 nitro 1,2,5 oxadiazol 3 yl)-methanediamine (MBANF)
Corporate Author:
Army Public Health Center Aberdeen Proving Ground United States
Report Date:
2020-03-01
Abstract:
The energetic and toxicological properties of n,n-bis4-nitro-1,2,5-oxadiazol-3-yl-methanediamine MBANF are under assessment as replacements for energetics in current use, such as such as hexahydro-1,3,5-trinitro-1,3,5-triazine RD and trinitrotoluene TNT. This study evaluated the skin sensitization hazard of MBANF through the h-CLAT, an in vitro approach to assess activation of dendritic cells. Data from the h-CLAT were also utilized to predict a Hazard Category UNECE2015 for acute oral toxicity. Data from this study are used to assist in making environment and health-based decisions regarding the design and selection of formulas and materials for development of new munition compounds.
Descriptive Note:
Technical Report,01 Feb 2020,31 Mar 2020
Pages:
0040
Distribution Statement:
Approved For Public Release;
File Size:
1.75MB
